A shadow economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Treatment Acquiring Traction Online
Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing effects. Viewers are urged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Separately, a robust market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day UK delivery. Vendors market the drug there before directing buyers to other platforms for purchases.
Learning About Retatrutide
This medication is an investigational injection developed by American pharmaceutical company Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, GIP and glucagon. Preliminary studies suggest it could help individuals reduce up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Voice Worries
Nevertheless, doctors and pharmacists have warned that the sale of what is still an unapproved medication in the United Kingdom is worrisome and could lead to individuals administering substances of unknown origin.
Some experts said the demand for the experimental drug could be linked to the increasing price of approved slimming treatments such as Mounjaro.
Regulatory Status and Implementation
Selling the unapproved drug on TikTok or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for human use under the Human Medicines Regulations 2012.
Some influencers attempt to circumvent the regulations by calling to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still breach medicines, marketing, and customer laws, risking fines, legal action or imprisonment.
Service Response and Content Removal
Based on TikTok, the service has taken down problematic material and prohibited related keywords and search suggestions. The organization stated it was dedicated to maintaining the platform safe and investing in strengthening compliance measures.
Online Trading Activities
Investigations also found groups with up to 9,000 members selling the experimental drug using Telegram's integrated search feature, which operates like a public directory. Entering “retatrutide” immediately displays groups with thousands of users, filled with images of weight loss, positive reviews and detailed guides for mixing or administering at residence.
Within minutes of joining one community, a vendor posted WhatsApp details, where the majority of purchases occur. The seller provided an instruction manual and promised shipping within 48 hours. When questioned whether the product was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one asked about weight, medical conditions or past usage.
Product Details and Pricing
Inside these communities, posts display dark colored packages with Royal Mail labels, stating to contain new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, mixed at home with purified liquid, or pre-filled injectors typically sold at 160 pounds for 20mg. When asked how much time a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Safety Measures
A spokesperson for Telegram stated it actively moderated harmful content on its platform including content that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Professional Cautions
“Individuals are administering materials they can’t verify. Even if the research behind retatrutide is sound, these digital versions may not contain what they claim,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.
A medical professional of an online medical service linked the increase in demand to recent price rises for authorized slimming drugs such as Mounjaro. “With costs rising, patients are turning to social media. But counterfeit injections are extremely dangerous. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.
Her staff has previously seen individuals harmed by self-injection from unverified suppliers. “We understand the frustration, but buying from messaging apps or WhatsApp is gambling with your health,” stated the doctor. “These materials could be impure or improperly measured.”
Manufacturer Statement
A spokesperson from Eli Lilly stated the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a Lilly investigational product not yet approved … may subject patients to possibly significant health risks”.